The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma

Treatment with rFVIIa reduced or stopped bleeding in all patients. No adverse events were registered. Prospective studies are mandatory to elucidate the role of rFVIIa in blunt trauma.